A publication dated October 11, 2026 titled "Mitochondrial-derived peptides in female reproduction: Emerging regulators of oocyte competence and novel therapeutic opportunities for infertility" appeared in the journal Tissue & Cell. The paper discusses mitochondrial-derived peptides, including MOTS-c, in the context of female reproductive biology. MOTS-c remains classified as an unapproved compound used only in research settings. This publication is listed in PubMed under identifier 42880137. The title indicates a focus on oocyte competence and potential therapeutic opportunities related to infertility, as framed by the authors. No specific findings, data, or conclusions from the publication are detailed here beyond its title and journal placement. Readers interested in the broader context of mitochondrial-derived peptides and their research applications should consult the full publication for complete details. This brief reports only the existence and bibliographic details of the publication as provided. For general background on MOTS-c and its research status, see the compound overview linked with this article.
New Publication Reviews MOTS-c Role in Female Reproduction
Source: https://pubmed.ncbi.nlm.nih.gov/42880137/